T-cell biomarkers improve urinary tract infection risk stratification beyond clinical characteristics after acute traumatic spinal cord injury

O Oliver Schweizerhof C Christian Meisel (Computational Neurology, Department of Neurology, Charité—Universitätsmedizin Berlin) C Christian Blex P Paolo Cinelli R Ralf Watzlawick T Tom Lübstorf L Laura-Christin Geurtz M Martin Kreutzträger E Elias Baumgartner J Julian Hirt M Magdalena Hoppe N Nadine Unterwalder U Uwe Kölsch R Ralf Böthig B Burkhard Domurath C Claudia Druschel K Klaus-Dieter Schaser A Andreas Niedeggen A Armin Curt M Michael G. Fehlings P Peter Vajkoczy A Axel Ekkernkamp T Thomas Liebscher J Jan M. Schwab M Marcel A. Kopp U Ulrike Grittner

Abstract

Abstract Patients with traumatic spinal cord injury (SCI) frequently develop urinary tract infections (UTI) which may compromise neurological rehabilitation. We explored risk factors for UTI, including immunological biomarkers, in patients with acute traumatic SCI during the transition from acute to subacute phase. Two observational studies were analysed separately: a retrospective study (COaT-SCI, n = 296, follow-up 13 weeks), and a prospective immunological study (SCIentinel, n = 70, follow-up 10 weeks). Cox regression models were used to examine associations of first UTI with patient characteristics and longitudinal immunological parameters. Cumulative incidence of first UTI was approximately 50% at six weeks. Results indicated higher UTI risk in older patients and time-varying associations for SCI severity (ASIA impairment scale) and presence of accompanying injuries. Higher cellular immune competence, particularly CD8 + T-cell counts and higher IFN-γ/IL-4 ratio in functional T-cell assays, were associated with a lower UTI risk (HR [95% CI] per log-transformed unit: CD8 + T-cells 0.34 [0.18—0.65], IFN-γ/IL-4 ratio 0.53 [0.33–0.83]). Adding cellular immune markers improved models’ discriminative ability (weighted C-index at 21 days from 0.68 to 0.76 with CD8 + T-cells). These findings indicate UTI is facilitated by systemic immune alterations, with T-cell parameters representing promising predictive biomarkers requiring further validation before clinical implementation.

Article Details

Volume / Issue Vol. 16, Issue 1
Published January 10, 2026
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (26)

O

Oliver Schweizerhof

C

Christian Meisel

Computational Neurology, Department of Neurology, Charité—Universitätsmedizin Berlin

C

Christian Blex

P

Paolo Cinelli

R

Ralf Watzlawick

T

Tom Lübstorf

L

Laura-Christin Geurtz

M

Martin Kreutzträger

E

Elias Baumgartner

J

Julian Hirt

M

Magdalena Hoppe

N

Nadine Unterwalder

U

Uwe Kölsch

R

Ralf Böthig

B

Burkhard Domurath

C

Claudia Druschel

K

Klaus-Dieter Schaser

A

Andreas Niedeggen

A

Armin Curt

M

Michael G. Fehlings

P

Peter Vajkoczy

A

Axel Ekkernkamp

T

Thomas Liebscher

J

Jan M. Schwab

M

Marcel A. Kopp

U

Ulrike Grittner